The Irish Government has agreed a supply deal with pharmaceutical company GSK, which will result in patients here being able to access the drugmaker's new Covid-19 treatment.
GSK and development partner Vir Biotechnology agreed a contract last year with the EU to supply up to 220,000 doses of sotrovimab for use by member states.
Last month the intravenously delivered drug received marketing authorisation in Europe, given Ireland and other member states who are part of the EU deal the freedom to order the treatment.